Survivin-Based Treatment Strategies for Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Survivin-Based Treatment Strategies for Squamous Cell Carcinoma

Published:2018-03-24 Issue:4 Volume:19 Page:971
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Santarelli Andrea,Mascitti Marco,Lo Russo Lucio,Sartini Davide,Troiano Giuseppe,Emanuelli Monica,Lo Muzio Lorenzo^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/4/971/pdf

Reference181 articles.

1. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma

2. Squamous cell carcinoma-similarities and differences among anatomical sites;Yan;Am. J. Cancer Res.,2011

3. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

4. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends

5. Management of high-risk cutaneous squamous cell carcinoma;Jennings;J. Clin. Aesthet. Dermatol.,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BIRC5 facilitates cisplatin‐chemoresistance in a m⁶A‐dependent manner in ovarian cancer;Cancer Medicine;2023-12-19

2. Prognostic impact of lymphovascular and perineural invasion in squamous cell carcinoma of the tongue;Scientific Reports;2023-03-07

3. Preoperative and postoperative evaluation of survivin in peripheral blood of patients with non-melanoma skin cancers. A pilot study;Journal of Dermatological Treatment;2023-01-19

4. The comparative evaluation of salivary survivin levels between different grades of oral squamous cell carcinoma;Biomedical and Biotechnology Research Journal (BBRJ);2023

5. Galectin-9 expression on tumor-associated immune cells is associated with favorable clinicopathological features and better outcomes in oral squamous cell carcinoma;Współczesna Onkologia;2023